PedAM
Pediatric Disease Annotations & Medicines
| Disease | graves disease |
| Phenotype | |hyperthyroidism |
| Sentences | 61 |
| PubMedID- 24465683 | The study enrolled 27 patients with hyperthyroidism due to graves' disease (25 women and 2 men). |
| PubMedID- 26218874 | graves' disease patients with persistent hyperthyroidism and diffuse lymphoplasmacytic infiltration in the thyroid show no histopathological compatibility with igg4-related disease. |
| PubMedID- 23177093 | hyperthyroidism due to graves' disease was found in 66.7% of patients, 41.6% of whom had received radioiodine therapy. |
| PubMedID- 24396691 | In addition, the recommendations in the kta consensus report are limited to the treatment of graves disease, because other causes of hyperthyroidism are relatively rare and the treatment of those diseases does not differ according to geographical area. |
| PubMedID- 26060588 | Methimazole (mmi) and propylthiouracil (ptu) are thionamide drugs, which are commonly used as first-line therapy in the treatment of hyperthyroidism due to grave's disease and toxic nodular goiter in the united states. |
| PubMedID- 24251139 | Described three patients with acromegaly who developed hyperthyroidism due to graves’ basedow disease in the course of their disease. |
| PubMedID- 22176499 | Patient findings: a 12-year-old african american girl with hyperthyroidism due to graves' disease and moderate persistent asthma, requiring oral prednisone, was treated with 11.1 mci of rai. |
| PubMedID- 21124799 | Tshr autoantibodies with either stimulatory (tsab) or blocking (tbab) activity are a key feature of autoimmune thyroid disease (aitd), with tsab having a pre-dominant effect in graves' disease (gd) leading to hyperthyroidism [1]. |
| PubMedID- 23806737 | Background: struma ovarii is a rare cause of hyperthyroidism, while coexistence with graves' disease has been scarcely reported. |
| PubMedID- 25777757 | The hyperthyroidism in graves' disease is caused by stimulation of function of thyrotropin hormone receptor (tshr), resulting from the production of agonist antibodies to the receptor. |
| PubMedID- 21563916 | Our aim was to find an optimum dosing strategy for (131)i treatment of hyperthyroidism due to graves' disease (gd). |
Page: 1 2